Involvement of interleukin 18 in lens opacification of otsuka long-evans tokushima fatty rats, a model of human type 2 diabetes

Current Eye Research

Volumn 36, Issue 6, 2011, Pages 497-506

  Nagai, Noriaki ^a   Murao, Takatoshi ^a   Ito, Yoshimasa ^a   Okamoto, Norio ^b   Okamura, Haruki ^b  

^a KINKI UNIVERSITY   (Japan)

^b HYOGO COLLEGE OF MEDICINE   (Japan)

Author keywords

Diabetes mellitus; Interferon ?; Interleukin 18; Lens opacification; OLETF rat

Indexed keywords

CHOLESTEROL; GAMMA INTERFERON; GLUCOSE; INTERLEUKIN 18; INTERLEUKIN 18 RECEPTOR ALPHA; INTERLEUKIN 1BETA CONVERTING ENZYME; MESSENGER RNA; TRIACYLGLYCEROL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CATARACT; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; CYTOKINE PRODUCTION; DATA ANALYSIS SOFTWARE; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE EXPRESSION; GLUCOSE BLOOD LEVEL; IMAGE ANALYSIS; MALE; MOUSE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OTSUKA LONG EVANS TOKUSHIMA FATTY RAT; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TRIACYLGLYCEROL BLOOD LEVEL;

ANIMALS; CATARACT; DIABETES MELLITUS, EXPERIMENTAL; DIABETES MELLITUS, TYPE 2; ENZYME-LINKED IMMUNOSORBENT ASSAY; GENE EXPRESSION REGULATION; INTERLEUKIN-18; LENS, CRYSTALLINE; MALE; RATS; RATS, INBRED OLETF; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER;

EID: 79956258993     PISSN: 02713683     EISSN: 14602202     Source Type: Journal    
DOI: 10.3109/02713683.2010.549602     Document Type: Article

References (50)

1. King H, Aubert RE, Herman WH. Global burden of diabetes, 1995-2025: Prevalence, numerical estimates, and projections. Diabetes Care. 1998;21:1414-1431.
2. Yoon KH, Lee JH, Kim JW, et al. Epidemic obesity and type 2 diabetes in Asia. Lancet. 2006;368:1681-1688.
3. Schrauwen P, Hesselink MK. Reduced tricarboxylic acid cycle flux in type 2 diabetes mellitus? Diabetologia. 2008;51:1694-1697.
4. Caird FI, Hutchinson M, Pirie A. Cataract extraction and diabetes. Br J Ophthalmol. 1965;49:466-471.
5. Harding JJ. Cataract: Biochemistry, Epidemiology and Pharmacology. London: Chapman and Hall; 1991.
6. Kubo E, Maekawa K, Tanimoto T, et al. Biochemical and morphological changes during development of sugar cataract in Otsuka Long-Evans Tokushima fatty (OLETF) rat. Exp Eye Res. 2001;73:375-381. (Pubitemid 32977203)
7. Toh T, Morton J, Coxon J, et al. Medical treatment of cataract. Clin Experiment Ophthalmol. 2007;35:664-671. (Pubitemid 47491225)
8. Li WC, Kuszak JR, Dunn K, et al. Lens epithelial cell apoptosis appears to be a common cellular basis for non-congenital cataract development in humans and animals. J Cell Biol. 1995;130:169-181.
9. Nagai N, Ito Y, Okamura H. Involvement of interleukin 18 in cataract development in hereditary cataract UPL rats. J Biochem. 2007;142:597-603. (Pubitemid 351197690)
10. Ghayur T, Banerjee S, Hugunin M, et al. Caspase-1 processes IFN-gamma some inducing factor and regulates LPS-induced IFN-gamma production. Nature. 1997;386:619-623. (Pubitemid 27175429)
11. Gu Y, Kuida K, Tsutsui H, et al. Activation of interferongamma inducing factor mediated by interleukin-1beta converting enzyme. Science. 1997;275:206-209. (Pubitemid 27034760)
12. Torigoe K, Ushio S, Okura T, et al. Purification and characterization of the human interleukin-18 receptor. J Biol Chem. 1997;272:25737-25742. (Pubitemid 27438893)
13. Kim SH, Reznikov LL, Stuyt RJ, et al. Functional reconstitution and regulation of IL-18 activity by the IL-18R beta chain. J Immunol. 2001;166:148-154. (Pubitemid 32038427)
14. Nakanishi K, Yoshimoto T, Tsutsui H, et al. Interleukin-18 regulates both Th1 and Th2 responses. Annu Rev Immunol. 2001;19:423-474. (Pubitemid 32368042)
15. Hoshino K, Tsutsui H, Kawai T, et al. Cutting edge: Generation of IL-18 receptor-deficient mice: Evidence for IL-1 receptor-related protein as an essential IL-18 binding receptor. J Immunol. 1999;162:5041-5044. (Pubitemid 29307100)
16. Moriwaki Y, Yamamoto T, Shibutani Y, et al. Elevated levels of interleukin-18 and tumor necrosis factor-alpha in serum of patients with type 2 diabetes mellitus: Relationship with diabetic nephropathy. Metabolism. 2003;52:605-608. (Pubitemid 36896287)
17. Escobar-Morreale HF, Botella-Carretero JI, Villuendas G, et al. Serum interleukin-18 concentrations are increased in the plycystic ovary syndrome: Relationship to insulin resistance and obesity. J Clin Endocrinol Metab. 2004;89:806-811. (Pubitemid 38269896)
18. Netea MG, Joosten LA, Lewis E, et al. Deficiency of interleukin- 18 in mice leads to hyperphagia, obesity and insulin resistance. Nat Med. 2006;12:650-656. (Pubitemid 43865233)
19. Esposito K, Nappo F, Marfella R, et al. Inflammatory cytokine concentrations are acutely increased by hyperglycemia in humans. Circulation. 2002;106:2067-2072. (Pubitemid 35192812)
20. Kawano K, Hirashima T, Mori S, et al. Spontaneous longterm hyperglycemic rat with diabetic complications. Otsuka Long-Evans Tokushima Fatty (OLETF) strain. Diabetes. 1992;41:1422-1428.
21. Ishida K, Mizuno A, Min Z, et al. Which is the primary etiologic event in Otsuka Long-Evans Tokushima Fatty rats, a model of spontaneous non-insulin-dependent diabetes mellitus, insulin resistance, or impaired insulin secretion? Metabolism. 1995;44:940-945.
22. Sato T, Asahi Y, Toide K, et al. Insulin resistance in skeletal muscle of the male Otsuka Long-Evans Tokushima Fatty rat, a new model of NIDDM. Diabetologia. 1995;38:1033-1041.
23. Ito A, Uriu K, Inada Y, et al. Inhibition of neuronal nitric oxide synthase ameliorates renal hyperfiltration in streptozotocininduced diabetic rat. J Lab Clin Med. 2001;138:177-185. (Pubitemid 32812230)
24. Yabuki A, Tahara T, Taniguchi K, et al. Neuronal nitric oxide synthase and cyclooxygenase-2 in diabetic nephropathy of type 2 diabetic OLETF rats. Exp Anim. 2006;55:17-25. (Pubitemid 43349427)
25. Hirashima T, Man ZW, Mori S, et al. OLETF rat. Diabetes Frontier. 1998;9:477-480.
26. Minami A, Ishimura N, Sakamoto S, et al. Effect of eicosapentaenoic acid ethyl ester v. oleic acid-rich safflower oil on insulin resistance in type 2 diabetic model rats with hypertriacylglycerolaemia. Br J Nutr. 2002;87:157-162. (Pubitemid 34575539)
27. Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem. 1987;162:156-159. (Pubitemid 17064313)
28. Felderhoff MU, Sifringer M, Polley O, et al. Caspase-1- processed interleukins in hyperoxia-induced cell death in the developing brain. Ann Neurol. 2005;57:50-59. (Pubitemid 40053315)
29. Nabekura T, Takeda M, Hori R, et al. Expression of plasma membrane Ca(2+)-ATPase in lenses from normal and hereditary cataract UPL rats. Curr Eye Res. 2001;22:446-450. (Pubitemid 34253203)
30. Nagai N, Fukuhata T, Ito Y, et al. Involvement of interleukin 18 in indomethacin-induced lesions of the gastric mucosa in adjuvant-induced arthritis rat. Toxicology. 2009;255:124-130.
31. Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem. 1976;72:248-254.
32. Ito Y, Cai H, Koizumi Y, et al. Correlation between prevention of cataract development by disulfiram and fates of selenium in selenite-treated rats. Curr Eye Res. 1999;18:292-299. (Pubitemid 29237889)
33. Kinoshita JH. Cataracts in galactosemia. (The Jonas S. Friendenwald Memorial Lecture). Invest Ophthalmol Vis Sci. 1965;4:786-799.
34. Kinoshita JH. Mechanisms initiating cataract formation. (Proctor Lecture). Invest Ophthalmol Vis Sci. 1974; 13;713-724.
35. Fukushi S, Merola LO, Kinoshita JH. Altering the course of cataracts in diabetic rats. Invest Ophthalmol Vis Sci. 1980;19:313-315. (Pubitemid 11067931)
36. Kador PF, Akagi Y, Kinoshita JH. The effect of aldose reductase and its inhibition on sugar cataract formation. Metabolism. 1986;35:5-19.
37. Akagi Y, Tasaka H, Terubayashi H, et al. In: N Sakamoto, JH Kinoshita, PF Kador, N Hotta (Ed.). Morphological classification of the prevention of aldose reductase inhibitor on rat galactose cataract. In: Current Concepts of Aldose Reductase and its Inhibition. New York: Elsevier, 1990; pp. 157-160. (Pubitemid 20363563)
38. Wakuta M, Morishige N, Chikama T, et al. Invest Ophthalmol Vis Sci. 2007;48:590-596
39. Awasthi N, Wagner BJ. Interferon-gamma induces apoptosis of lens alphaTN4-1 cells and proteasome inhibition has an antiapoptotic effect. Invest Ophthalmol Vis Sci. 2004;45:222-229. (Pubitemid 38055691)
40. Aizawa Y, Akita K, Taniai M, et al. Cloning and expression of interleukin-18 binding protein. FEBS Lett. 1999;445:338-342 (Pubitemid 29117240)
41. Novick D, Kim SH, Fantuzzi G, et al. Interleukin-18 binding protein: A novel modulator of the Th1 cytokine response. Immunity. 1999;10:127-136. (Pubitemid 29077390)
42. Hurgin V, Novick D, Rubinstein M. The promoter of IL-18 binding protein: Activation by an IFN-gamma -induced complex of IFN regulatory factor 1 and CCAAT/enhancer binding protein beta. Proc Natl Acad Sci U S A. 2002;99:16957-16962. (Pubitemid 36034080)
43. Kuwabara T. The maturation of the lens cells: A morphologic study. Exp Eye Res. 1975;20:427-443.
44. Zelenka PS, Gao CY, Rampalli A, et al. Cell cycle regulation in the lens: Proliferation, quiescence, apoptosis and differentiation. Prog Retin Eye Res. 1997;16:303-322. (Pubitemid 27060195)
45. Wride MA. Minireview: Apoptosis as seen through a lens. Apoptosis. 5:203-209.
46. Lee EH, Wan XH, Song J, et al. Lens epithelial cell death and reduction of anti-apoptotic protein Bcl-2 in human anterior polar cataracts. Mol Vis. 2000;8:235-240. (Pubitemid 36153613)
47. Harocopos GJ, Alvares KM, Kolker AE, et al. Human age- related cataract and lens epithelial cell death. Invest Ophthalmol Vis Sci. 1998;39:2696-2706. (Pubitemid 28558229)
48. Kilic F, Handelman GJ, Serbinova E, et al. Modelling cortical cataractogenesis 17: In vitro effect of a lipoic acid on glucose- induced lens membrane damage, a model of diabetic cataractogenesis. Biochem Mol Biol Int. 1995;37:361-370. (Pubitemid 26176472)
49. Nagai N, Ito Y, Takeuchi N. Inhibitive effects of enhanced lipid peroxidation on Ca(2+)-ATPase in lenses of hereditary cataract ICR/f rats. Toxicology 2008;247:139-144.
50. Nagai N, Ito Y. Adverse effects of excessive nitric oxide on cytochrome c oxidase in lenses of hereditary cataract UPL rats. Toxicology. 2007;242:7-15. (Pubitemid 350087427)